Immunotherapy for advanced gastric and esophageal cancer: preclinical rationale and ongoing clinical investigations

Journal of Gastrointestinal Oncology

Samuel J. Klempner¹  Alexander G. Raufi² 

[1] Department of Medicine, Orange, CA, USADepartment of Medicine, Orange, CA, USADepartment of Medicine, Orange, CA, USA

关键词: Immunotherapy;    gastric;    esophageal;    cancer;    programmed death ligand 1 (PD-L1);    checkpoint;    programmed cell death protein 1 (PD-1);   

DOI  :  10.3978/j.issn.2078-6891.2015.037

学科分类：肿瘤学

来源: Pioneer Bioscience Publishing Company

【 授权许可】

Unknown